Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Cardiovascular Conditions
Vol. 5, Issue 1, 2017
May 05, 2017 EDT
Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
Yazid Aoudia
,
Thitima Kongnakorn
,
Evie Merinopoulou
,
Mohamed Said Bettayeb
,
Sid Ahmed Kherraf
,
algeria
aspirin
rivaroxaban
acenocoumarol
atrial fibrillation
cost-effectiveness
apixaban
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9797
JHEOR
1.
Aoudia Y, Kongnakorn T, Merinopoulou E, Bettayeb MS, Kherraf SA. Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria.
JHEOR
. 2017;5(1):39-54.
doi:10.36469/9797
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats